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Genome instability is a recurring feature of tumorigenesis. Mutation inMLL2, encoding a histone methyltrans-
ferase, is a driver in numerous different cancer types, but the mechanism is unclear. Here, we present evidence that
MLL2mutation results in genome instability. Mouse cells in which MLL2 gene deletion can be induced display
elevated levels of sister chromatid exchange, gross chromosomal aberrations, 53BP1 foci, and micronuclei. Human
MLL2 knockout cells are characterized by genome instability as well. Interestingly, MLL2 interacts with RNA po-
lymerase II (RNAPII) and RECQL5, and, althoughMLL2mutated cells have normal overall H3K4me levels in genes,
nucleosomes in the immediate vicinity of RNAPII are hypomethylated. Importantly, MLL2mutated cells display
signs of substantial transcription stress, and themost affected genes overlap with early replicating fragile sites, show
elevated levels of γH2AX, and suffer frequent mutation. The requirement for MLL2 in the maintenance of genome
stability in genes helps explain its widespread role in cancer and points to transcription stress as a strong driver in
tumorigenesis.
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It has become increasingly clear that transcription, an es-
sential and tightly regulated process, is associated with
genome instability (Aguilera and Gomez-Gonzalez 2008;
Svejstrup 2010). The mechanisms are still poorly under-
stood, but transcription-associated genome instability is
at least partly caused by clashes with the replication fork,
resulting in mutagenesis or chromosomal breaks that can
lead to genome reorganization (Bermejo et al. 2012; Kim
and Jinks-Robertson 2012; Helmrich et al. 2013). Since
the acquisition of genomic instability is a pivotal event
during tumorigenesis (Hanahan and Weinberg 2011), un-
derstanding themechanisms thatmaintain genome integ-
rity during transcription is of great importance.
We recently reported that RECQL5, a member of the
RECQ family of helicases, is a general RNA polymerase
II (RNAPII) elongation factor that is important for preserv-
ing genomic stability during transcription (Saponaro et al.
2014). Indeed, depletion of RECQL5 results in increased
pausing, stalling, arrest, and/or backtracking (collectively
referred to as transcription stress) at sites that overlap
with regions of genome instability. RECQL5 serves as an
interesting example of proteins that function at the inter-
face between several cellular processes, such as transcrip-
tion, DNA replication, and recombination, to maintain
genome integrity.
Chromatin poses a substantial challenge for the tran-
scribing RNAPII. As it transcribes through nucleosomes,
RNAPII interacts with chromatin-modifying enzymes,
affecting chromatin structure and nucleosome displace-
ment/reassembly. In the absence of tightly regulated
cotranscriptional chromatin rearrangement, transcript
elongation can be interrupted, resulting in transcription
stress andpotential disturbance of the integrityof the tran-
scribed region (Svejstrup 2007; Selth et al. 2010; Saponaro
et al. 2014). In light of these considerations, it is intriguing
that mutations in chromatin-regulating enzymes have
been identified in several recent cancer genome-sequenc-
ing projects (for recent reviews, see Roy et al. 2014; Van
Rechem and Whetstine 2014). For example, the gene en-
codingMLL2, a histoneH3Lys4 (H3K4)methyltransferase
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(HMT), is mutated in a large number of different cancers.
These include diffuse large B-cell lymphoma (Pasqualucci
et al. 2011), follicular lymphoma (Okosun et al. 2014), me-
dulloblastoma (Parsons et al. 2011; Pugh et al. 2012), pedi-
atric cancers (Huether et al. 2014), breast cancer (Stephens
et al. 2012), lung carcinomas (The Cancer Genome Atlas
Research Network 2012; Ross et al. 2014; Yin et al.
2014), parathyroid carcinoma (Kasaian et al. 2013), esoph-
ageal squamous cell carcinoma (Gao et al. 2014; Song et al.
2014), head and neck squamous carcinomas (Seiwert et al.
2015), renal carcinoma (Dalgliesh et al. 2010), urothelial
bladder carcinoma (Balbas-Martinez et al. 2013), and pros-
tate cancer (Grasso et al. 2012).
MLL2 (also known as ALR or KMT2D; human gene ID
8085; originally called MLL4 in mice) is the largest mem-
ber (594 kDa) of the Trithorax-type HMTs (Ruthenburg
et al. 2007). In mammals, this group of enzymes also in-
cludes SETD1A, which appears to be responsible for the
majority of cellular H3K4 trimethylation (H3K4me3) (Ble-
dau et al. 2014), as well asMLL1,MLL3, andMLL4.MLL1
has been extensively studied due to its well-established
role in leukemia (Li and Ernst 2014), but less is known
about the othermembers of the group. The closely related
proteins MLL2 and MLL3 reside in nearly identical com-
plexes, termed ASCOM (Lee et al. 2009). Recent studies
have provided evidence for a role for MLL2 and MLL3 in
histone H3K4 methylation at enhancers (Hu et al. 2013;
Lee et al. 2013; Cheng et al. 2014), and it has thus been
suggested that their role in cancer might be explained
through deregulated expression of oncogenes and tumor
suppressors (Herz et al. 2014). However, the transcrip-
tome of cells lacking MLL2 shows remarkably few differ-
ences from that of the wild-type counterpart, leaving few
clues to explain tumorigenesis this way (Issaeva et al.
2007; Guo et al. 2012).
In the process of generating interactomes for a number
of transcription proteins, we observed that MLL2 associ-
ates with RECQL5, prompting us to investigate whether
MLL2 might play a role in maintaining genome stability
in genes. Herewe report thatMLL2mutation indeed gives
rise to significant genomic instability in areas overlapping
with early replicating fragile sites (ERFSs). Thismay be ex-
plained by the involvement of MLL2 in transcript elonga-
tion and specifically in mediating elongation-associated
histone H3K4 methylation. Indeed, cells mutated for
MLL2 display significant transcription stress in short,
highly active genes, which overlap with the sites of ge-
nome instability. Together, these findings can potentially
explain the surprisingly widespread involvement ofMLL2
in human cancer.
Results
MLL2 interacts with RECQL5
A human cell line expressing a Flag-tagged version of the
RECQL5 protein (Aygun et al. 2008) was used to perform
affinity purification experiments followed by mass spec-
troscopy. This established that RECQL5 associates with
RNAPII subunits and several transcription-related fac-
tors, including elongation factors (SPT5 and SPT6), and
the Mediator and Integrator complexes (Supplemental
Fig. S1; Supplemental Table S1). These results comple-
mented previous data showing that RECQL5 interacts
with the elongating form of RNAPII (Aygun et al. 2008).
Unexpectedly, however, we also detectedMLL2with high
confidence (Supplemental Fig. S1A). Subsequent high-
sensitivity mass spectroscopy analysis confirmed the in-
teraction between RECQL5 and MLL2, and several other
components of the MLL2 complex were now also identi-
fied, including the PTIP subunit (see Fig. 5, below; Supple-
mental Fig. S1B; Supplemental Table S2). Notably, we
consistently failed to detect MLL3 in these experiments.
Mouse cells defective for MLL2 present genomic
instability
RECQL5 has a well-established role in maintaining geno-
mic stability (Aygun and Svejstrup 2010; Saponaro et
al. 2014). While the mechanistic relevance of MLL2–
RECQL5 interaction is yet to be investigated, the connec-
tion spurred us to investigate the potential role of MLL2
in the maintenance of genome integrity. For this purpose,
we initially used immortalized mouse embryonic fibro-
blasts (MEFs) in which both MLL2 alleles were targeted
by loxP (F/F cells). Addition of tamoxifen to these
cells for 24 h resulted in the complete excision of MLL2
exons 3–5 (hereafter referred to as FC/FC cells), loss of
mRNA over the targeted regions, and a change in reading
frame that inserts a stop codon, as designed (Supplemental
Fig. S2).
MLL2 FC/FC and control cells were used in a variety of
assays to test the hypothesis thatMLL2 affects genome in-
tegrity. First, we measured sister chromatid exchange in
MLL2 FC/FC and the parental F/F cells as well as indepen-
dently derived +/FC control cells and their parental +/F
cells. The latter cells were included to exclude the possi-
bility that expression of Cre recombinase in itself had an
effect. Interestingly, although sister chromatid exchange
was measured after only a limited number of cell dou-
blings afterMLL2 excision, the FC/FC cells presented sig-
nificantly higher levels of exchange than parental cells,
while this was not the case for the +/FC control cells
(Fig. 1A).
We next looked at gross chromosomal aberrations
(GCAs), including radial chromosomes, chromosomal fu-
sions, and chromatid breakages. The FC/FC cells present-
ed significantly higher levels of GCAs than the paternal
cells, at a level similar to that of cells treated with camp-
tothecin (CPT), a topoisomerase 1 inhibitor that generates
DNA damage. Not surprisingly, the number of GCAs in
the FC/FC cells increased even further after treatment
with CPT (Fig. 1B).
If manipulation ofMLL2 indeed results inDNA lesions,
then these might be marked by phosphorylation of
H2AX (a form designated γH2AX) (Rogakou et al. 1998),
while 53BP1 nuclear bodies (Lukas et al. 2011) might
also be manifested. Indeed, elevated levels of 53BP1 foci
that colocalized with γH2AX were frequently detected
in FC/FC cells (Fig. 1C, right panel). Using automatic
MLL2 in transcription and genome instability
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recognition software for quantification (Carpenter et al.
2006), a threefold or greater increase in 53BP1 foci was ob-
served in the FC/FC cells 1 wk after MLL2 excision (Fig.
1C, left panel). No difference was detected between
+/FC and +/F cells (Supplemental Fig. S3A). Interestingly,
the increase in 53BP1 foci in FC/FC cells was only tran-
sient, as the levels were consistently indistinguishable
from the controls when cells were instead grown for 4
wk (Fig. 1C, left). We also scored the cells for the presence
of micronuclei as another sensitive indicator of genome
instability. A marked increase of micronuclei was ob-
served in FC/FC cells, which, like the increase in 53BP1
foci, was transient (Supplemental Fig. S3B). As expected,
control cells showed no significant change (Supplemental
Fig. S3C). A trivial explanation for the transient nature of
some of these changesmight be if a subgroup of cells failed
to excise MLL2 and were then clonally expanded during
subsequent cell culture. However,MLL2 loss was similar-
ly complete in cells grown for 1 wk and 1 mo (data not
shown). This suggests that cells become genomically un-
stable immediately after the loss of MLL2 function but
somewhat stabilize with time so that only some features
of genome instability remain observable.
Similar to our previous analysis of RECQL5 (Saponaro
et al. 2014), we also used comparative genomic hybridiza-
tion (CGH) to detect genomic regions that were gained or
lost as a result of disabling MLL2 function. A limited
number of recurring events was identified (Supplemental
Fig. S4A), which occurred independently in two experi-
ments performed 1 or 4 wk afterMLL2 excision. We con-
firmed by γH2AX chromatin immunoprecipitation (ChIP)
that the regions encompassing the break sites detected by
CGH were indeed subject to genomic alteration/damage
(Supplemental Fig. S4B).
Together, the data above provide compelling evidence
that MLL2 mutation results in genome instability. To
confirm that the cellular defects above were due to loss
of MLL2 function, we used a stable F/F cell line carrying
Figure 1. Genomic instability phenotypes
inMLL2 FC/FCmouseMEF cells. (A) Sister
chromatid exchange quantification. Each
dot represents a metaphase. n = 60 meta-
phases for each cell line. The red arrows in-
dicate sister chromatid exchange events. (B)
Gross chromosomal aberration (GCA)
quantification in the presence or absence
of camptothecin (CPT). Representative ex-
amples of aberrations are shown in the im-
ages at the right. n≥ 100 metaphases for
each cell line/treatment. (C ) Immunofluo-
rescence using antibodies against 53BP1
(red) and γH2AX (green). Nuclei are shown
in blue. n = 3 independent experiments
scoring >500 cells in total for each cell
line. (D) GCA quantification in MLL2
BAC rescue experiments. n≥ 100 meta-
phases from two different MLL2 bacterial
artificial chromosome (BAC) clones for
each cell line. (E) 53BP1 quantification in
MLL2 BAC rescue experiments. n = 6 inde-
pendent experiments from two different
MLL2 BAC clones scoring >1500 cells in to-
tal for each cell line. P-values were deter-
mined by Mann-Whitney test. Error bars
represent SEM. For all figures in this study,
P < 0.05 (∗), P < 0.01 (∗∗), P < 0.001 (∗∗∗),
P < 0.0001 (∗∗∗∗), and not significant (ns).
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a bacterial artificial chromosome (BAC) expressing wild-
typeMLL2, aswe could not consistently and convincingly
detect the ∼600-kDa MLL2 protein by Western blotting.
The resulting cell line was treated with tamoxifen to ex-
cise the floxed MLL2 alleles but leave the BAC-encoded
allele intact. Gratifyingly, FC/FC cells expressing MLL2
from the integrated BAC had levels of GCAs and 53BP1
foci that were indistinguishable from the parental cells
(Fig. 1, cf. D,E and B,C, respectively).
We conclude that mutation ofMLL2 in mouse cells re-
sults in genomic instability.
Human cells defective for MLL2 show genome
instability as well
Wealso investigatedwhetherMLL2 affects genome stabil-
ity in human cells. For this purpose, we used two indepen-
dently derivedMLL2knockout cell lines: KO19 andKO34.
As controls, the parental HCT116 line as well as aMLL2-
Flag wild-type cell line were used (all were from Guo
et al. 2012). As expected from the experimentswithmouse
cells, human cells lackingMLL2 had higher levels of sister
chromatid exchange compared with the two control cell
lines (Fig. 2A). The human MLL2 knockout cells did not
show GCAs under normal conditions but were signifi-
cantly more sensitive than the controls to treatment
withCPT (Fig. 2B).We alsomeasured 53BP1 foci in the hu-
manMLL2 knockouts but found no significant difference
(Supplemental Fig. S3D). Given that these human cells
are stable knockout lines, this was not unexpected, as
thenumberof 53BP1 fociwere also only transiently elevat-
ed in themouseMLL2 FC/FC cells (see Fig. 1C). In general,
these experiments are consistent with the idea thatMLL2
mutation promotes transient and substantial genome in-
stability, which, to some extent, stabilizes with time.
We also hypothesized that since the human MLL2
knockouts are stable cell lines that have undergone sever-
al divisions withoutMLL2, copy number changes in geno-
mic loci might have accumulated to a higher level than
that observed in the mouse cell lines. We therefore again
performed CGH experiments, this time comparing the
two independently derived human MLL2 knockouts
with the parental or Flag-tagged cell lines. We detected
18 aberrations (11 gains and seven losses) thatwere detect-
ed in either one or both knockout lines, compared with
the controls (Supplemental Fig. S5A).
Gene expression microarray analyses using the same
cell lines have already been published, and only relatively
few genes are affected byMLL2 deletion (Guo et al. 2012).
Given that several different genomic regions are lost or
gained with a high frequency in the humanMLL2 knock-
out cells, we compared the list of genes whose expression
was affected by MLL2 deletion (Guo et al. 2012) with the
genes that were affected by the genomic gains or losses
in our CGH assays. Remarkably, close to one out of five
of the genes with lower expression in MLL2 knockout
cells are located in genomic regions that were lost, while
approximately one in 10 of the genes with higher expres-
sion are in genomic regions that were called as gains in
our CGH analysis. The gene with the lowest level of ex-
pression in MLL2 knockout cells, COL4A5 (Guo et al.
2012), was actually completely lost in bothMLL2 knock-
out cells lines, as confirmed by quantitative PCR (qPCR)
of genomic DNA (Fig. 2C). These experiments show that
lack of MLL2 can result in losses or gains of genomic
loci, which in turn may affect the transcriptome and be
Figure 2. MLL2 maintains genomic stability in hu-
man HCT116 cells. (A) Sister chromatid exchange
quantification. The parental and MLL2 Flag-tagged
cellswereusedas controls. Eachdot represents ameta-
phase. n = 60 metaphases for each cell line. (B) GCA
quantification in the presence or absence of CPT. n≥
100 metaphases for each cell line or treatment. (C,
left) CGH profile of chromosome X (chrX) in MLL2
KO19 cells compared with the parental line. The
COL4A5/6 locus at q22.3 is lost. (Right) Genomic
DNA PCR for the COL4A5/6 locus. (D) CGH profile
of chromosome 8 (chr8) inMLL2KO19 andΔSET cells
compared with the parental line. Error bars represent
SEM. P-values were determined by Mann-Whitney
test.
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misinterpreted as reduced levels of transcription by gene
expression analysis.
We next investigated whether the SET domain, the cat-
alytic methyltransferase domain of MLL2, might be im-
portant for maintaining genome stability. To this end,
we again used a human cell line derived by the He labora-
tory (Guo et al. 2013) that expresses a form of MLL2 lack-
ing the SET domain, located at the extreme C-terminal of
the protein (ΔSET). Remarkably, sister chromatid ex-
change assays showed not only that ΔSET cells had a sig-
nificantly higher number of exchange events than the
parental and Flag-tagged control cells but that genomic in-
stability was significantly increased even compared with
the MLL2 knockout cell lines (Fig. 2A). Moreover, we
found that, in contrast to the knockout cells, the meta-
phase chromosomes of the ΔSET cells had a significantly
elevated number of abnormalities even in the absence of
CPT, which was further increased by CPT treatment
(Fig. 2B). Together, these data indicate that cells express-
ing MLL2 lacking the SET domain show even more ge-
nome instability than cells expressing no MLL2 at all.
To further expand on this finding, we performed CGH
experiments to map gains and losses in the ΔSET cells.
Twenty-nine aberrations (15 losses and 14 gains) were un-
covered (Supplemental Fig. S5B). Interestingly, half of the
aberrations (nine of 18) found in the knockout cell lines
were also detected in the ΔSET cells. On the other hand,
certain aberrations, such as the loss of COL4A5 (Fig.
2C), were not observed in the ΔSET cells, and vice versa.
Moreover, some regions, such as on chromosome 8,
were lost to an even larger extent in ΔSET cells than in
the knockout cell lines (Fig. 2D).
Together, the data presented thus far indicate that
MLL2 is important for maintaining genome stability in
both mouse and human cells and that loss of its SET
domain strongly affects the process.
Elevated levels of transcription-associated DNA damage
in MLL2 mutants
The data above establish that MLL2 mutation results in
pronounced genome instability, but the underlyingmech-
anism remained unclear. We first considered the possibil-
ity that genome instability in the MLL2 mutated cells
might be brought about indirectly; for example, through
deregulation of repair genes. However, MLL2 mutation
had a barely discernable effect on gene expression in our
mouse cells, as previously observed in human cells
(Issaeva et al. 2007; Guo et al. 2012). Indeed, we found
that only 37 genes showed increased expression, while
55 had decreased expression (greater than twofold) in
MLL2 FC/FCmouse cells (Supplemental Table S3). Impor-
tantly, none of the encoded proteins are involved in the
maintenance of genome stability.
To try to identify specific sites of genome instability in
MLL2 FC/FC cells, we performed genome-wide analysis
with γH2AX as a proxy for DNA damage and H2AX and
H3 as controls. As previously noted by others (Iacovoni
et al. 2010; Seo et al. 2012), γH2AX was enriched in tran-
scribed regions and depleted from intergenic regions (Sup-
plemental Fig. S6A,B). We therefore focused our further
analysis on genes. Importantly, many genes had signifi-
cantly higher levels of γH2AX in MLL2 FC/FC cells. As
amatter of fact, themost affected genes (414; 10%of total)
had almost 50% higher γH2AX density, on average, in
MLL2 FC/FC cells than in wild type (Fig. 3A; Supplemen-
tal Table S4). The validity of the ChIP sequencing (ChIP-
seq) data were confirmed by ChIP-qPCR experiments for
several genes (Supplemental Fig. S6C), and we also con-
firmed the γH2AX occupancy data using a distinct anti-
γH2AX antibody (Supplemental Fig. S6D). More modest
average increases for γH2AX occupancy were observed
when all active genes were computed (Fig. 3A, all active).
Importantly, little or no increase in the levels of the
(unphosphorylated) H2AX histone variant itself was
detected in MLL2 FC/FC cells (Fig. 3A), supporting the
conclusion that the elevated γH2AX levels indeed sig-
nify DNA damage, as expected. Together, these data are
consistent with the chromosome-level results presented
in Figures 1 and 2: MLL2 mutation results in DNA
damage—marked by γH2AX, which can be mapped by
ChIP-seq to high resolution—and appears to be particu-
larly prevalent in a subset of genes. As a representative ex-
ample, γH2AX density was clearly increased across the
HIST1H1D gene in MLL2 FC/FC cells (Fig. 3B, left, top
two panels; see also Supplemental Fig. S7A).
Because MLL2 interacts with elongation factor
RECQL5, we also characterized transcript elongation and
transcription stress in particular. For this purpose, we
combined RNAPII ChIP-seq with genome-wide nuclear
run-on sequencing (GRO-seq) analysis. Indeed, RNAPII
ChIP-seq data can be difficult to interpret in isolation.
For example, accumulation of RNAPII in the transcribed
region of a gene can be explained in two different ways:
by increased rates of transcriptional initiation (and thus
elevated transcription/RNAPII levels) or, in stark con-
trast, by “slow elongation” such as that caused by tran-
scription stress (see Ehrensberger et al. 2013 for details).
Crucially, GRO-seq data can distinguish between these
possibilities. Indeed, if the rise in RNAPII ChIP density
inside a gene is due to higher initiation rates, then na-
scent transcription (the GRO signal) should also be ele-
vated. Otherwise, it must be due to slow elongation/
transcription stress (referred to here as transcription
stress for simplicity). To identify genes with transcrip-
tion stress in MLL2 FC/FC cells, we thus selected genes
that had elevated levels of RNAPII by ChIP-seq but did
not have a correlating increase in nascent transcription
—i.e., GRO-seq—levels. As a representative example,
RNAPII occupancy was clearly increased across the
HIST1H1D gene in MLL2 FC/FC cells, while nascent
transcription was reduced (Fig. 3B, four bottom panels;
see also Supplemental Fig. S7A). We confirmed the
sequencing data at this and a couple of other genes by
independent ChIP-qPCR experiments (Supplemental
Fig. S7B).
In an initial attempt to address whether genes experi-
encing DNA damage also showed transcription stress,
we now focused on the promoter-proximal region (tran-
scription start site [TSS] ± 2 kb) of the 414 genes that had
Kantidakis et al.
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the highest levels of DNA damage (γH2AX) inMLL2 FC/
FC cells. Interestingly, not only γH2AX but also RNAPII
occupancy was elevated in this region in MLL2 FC/FC
cells and particularly so in the transcribed region from
500 base pairs (bp) downstream from theTSS, in the region
where processive transcript elongation gets under way
(Fig. 3C,D, see stippled boxes). Remarkably, however, al-
though the mean RNAPII occupancy was clearly in-
creased in the FC/FC cells (Fig. 3D), the level of nascent
RNAPII transcription remained the same or was slightly
decreased (Fig. 3E). A similar trend, but to a much smaller
extent, was observed in active genes in general but with-
out a noticeable increase in γH2AX levels (Supplemental
Fig. S8A–C). The uncoupling of RNAPII occupancy and
nascent mRNA production strongly indicates that tran-
script elongation is perturbed in the absence ofMLL2, cor-
relating with DNA damage at the most affected genes. As
slow elongation will not normally affect gene expression
levels (Ehrensberger et al. 2013), this is also in agreement
with the finding thatMLL2mutation affects the dynamics
of transcription but not steady-state levels of mRNA ex-
pression at these genes.
Increased transcription stress is associated
with DNA damage
Tomore generally examine the connection betweenDNA
damage and slow elongation/transcription stress inMLL2
FC/FC cells, the extent of overlap between them was an-
alyzed. As indicated above, we defined “transcription
stress genes” as those with a RNAPII ChIP-seq ratio of
>1 and a GRO-seq ratio of <1 in MLL2 FC/FC cells com-
pared with the F/F controls. There were 2158 such tran-
scription stress genes. Remarkably, among the 216
(10%) genes with the highest level of transcription stress,
99 (46%)were also found among the 414 that had themost
DNA damage (Fig. 4A, left). We also compared the ranked
lists of transcription stress genes and genes with elevated
DNA damage. As expected, genes with high transcription
stress were significantly enriched at the top of the list of
genes with DNA damage (P-value = 1.4 × 10−60, Kolmogo-
rov-Smirnoff test) (see also Fig. 4A, right). Together, these
data indicate that transcription stress in MLL2 mutated
cells is accompanied by DNA damage.
Bioinformatic analysis of the groupof 414geneswith the
mostDNAdamage inMLL2 FC/FC cells showed that they
arehighly transcribed (Fig. 4B) and small in size,with ame-
dian length of only 4.1 kb versus 10.6 kb for all active genes
in these cells (Fig. 4C). Not surprisingly, similar numbers
characterized the 216 genes with the most transcription
stress, which had amedian length of 3.9 kb (Supplemental
Fig. S8D).We note that, as the affected geneswere general-
ly short, the area of elevated DNA damage (γH2AX) ana-
lyzed above (Fig. 3) in effect represents a substantial
proportion of the transcribed region of these genes. It is
of particular note that 26 of the 414 genes with high levels
of damage represent one of the 61 histone genes expressed
in these cells; i.e., >40%ofhistonegeneshadhighly elevat-
ed levels ofDNAdamage (γH2AX)whenMLL2wasmutat-
ed (P = 1.8 × 10−11, hypergeometric test). This interesting
finding is explored in more detail below.
We also investigated whether the genes with the most
DNA damage in MLL2 mutated cells overlapped with
Figure 3. RNAPII ChIP-seq, γH2AX ChIP-seq, and ge-
nome-wide nuclear run-on sequencing (GRO-seq) pro-
files in MLL2 mutated cells. (A) Fold change variation
in γH2AX/H3, H2AX/H3, RNAPII ChIP-seq density lev-
els and GRO-seq levels over the gene body ±500 base
pairs (bp) in FC/FC versus F/F cells in all actively tran-
scribed genes or genes with the most DNA damage, as
indicated. Thewhiskers denoteminimum tomaximum.
The depicted arithmetic values represent geometric
mean differences. (B) ChIP-seq profiles over the
HIST1H1D gene for γH2AX, RNAPII, and GRO-seq in
F/F and FC/FC cells. Profiles of γH2AX (normalized to
H3) (C ), RNAPII (D), or GRO (E) for the genes with the
most DNA damage.
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known sites of genome instability. Remarkably, no less
than 25% (105 of 414) of the genes with the most DNA
damage and 33% (71 of 216) of the transcription stress
genes inMLL2 FC/FC cells overlapped with a class of can-
cer-associated chromosome fragile sites recently named
ERFSs (Barlow et al. 2013). The probability of this being
a chance event is 5.5 × 10−5 and 7.34 × 10−8, respectively
(hypergeometric test). Replication programs are cell
type-specific (Letessier et al. 2011), and, while MLL2-re-
lated DNA damage (γH2AX) and transcription stress
weremapped in fibroblasts in the present study, the ERFSs
weremapped in lymphocytes (Barlow et al. 2013), making
the overlap all the more noteworthy.
We conclude that MLL2 mutation results in transcrip-
tion stress and DNA damage in short, highly active genes
that overlap with previously mapped, cancer-associated
ERFSs.
MLL2 mutation affects RNAPII-associated histone
methylation but not general histone methylation
Given that MLL2 is a histone methyltransferase, we now
investigated whether the genes had measurable decreases
in H3K4 methylation in MLL2 FC/FC cells. Little if any
difference in histone H3K4 methylation was observed
across all genes between FC/FC and F/F cells (Fig. 5A,
left; Supplemental Fig. S9A,B, left), and mono-, di-, and
trimethylation were actually marginally elevated rather
than decreased at the 414 most damaged genes in MLL2
FC/FC cells (Fig. 5A, right; Supplemental Fig. S9A,B,
right). In agreement with these data, others have previous-
ly reported that no decrease in histone methylation levels
is observed in human and Drosophila cells lacking MLL2
(Herz et al. 2012; Hu et al. 2013).
Consistent with recent studies showing thatMLL2mu-
tation affects H3K4 methylation at enhancers (Hu et al.
2013; Lee et al. 2013; Cheng et al. 2014), we did detect po-
tential mouse enhancers and other regulatory elements
where H3K4 mono- and dimethylation in particular
were affected (Supplemental Fig. S9C), but γH2AX-, RNA-
PII-, and GRO-levels were not significantly affected in
these locations (Supplemental Fig. S9D).
Given that histone methylation was not markedly de-
creased in the MLL2 mutated cells, we investigated
whether MLL2 is normally present at genes, such as the
highly γH2AX-enriched histone genes. The genome-
wide occupancy ofMLL2 has previously been investigated
by ChIP-seq in HCT116 cells (Hu et al. 2013). Moreover,
the RNAPII ChIP-seq profile for this cell type is available
through the ENCODE project (The ENCODE Project
Consortium 2012). Remarkably, these data show that
MLL2 is indeed detected at human histone genes, with
its density distribution nicely mirroring that of RNAPII
(Fig. 5B). We also used the same data sets to performmeta-
gene analysis of RNAPII and MLL2 density, specifically
over gene bodies. As expected, RNAPII showed the char-
acteristic profile with a prominent peak over the TSS
and a smaller peak at the transcription termination site
(TTS) (Fig. 5C, left). Remarkably, however, the metapro-
file of MLL2 was similar (Fig. 5C, right), supporting the
conclusion that MLL2 is more directly involved in tran-
scription than has previously been recognized.
Given these data, we now investigated whether MLL2
interacts with RNAPII as well as RECQL5. As expected
from the mass spectroscopy analysis of RECQL5, MLL2
could indeed coimmunoprecipitate RECQL5 (Fig. 5D).
Furthermore, MLL2 interacted with not only PTIP but
also different phosphorylated forms of RNAPII and also
unphosphorylated RNAPII (as detected by the 8WG16 an-
tibody) (Fig. 5D). The reverse was also true, as RNAPII
coprecipitated Flag-tagged MLL2 and PTIP (Fig. 5E). The
interaction with RNAPII, combined with its genomic pro-
file over gene regions, thus suggests that MLL2 should be
viewed as a general transcription-associated factor.
Figure 4. Genes with transcription stress and genes
with DNA damage overlap. (A, left) Forty-six percent of
the genes with the most transcription stress have high
levels of DNA damage (γH2AX). (Right) The γH2AX Z-
scores of all active genes were plotted (red), with the
216 genes with most transcription stress indicated in
blue. (B) Genes with high levels of DNA damage in
MLL2 FC/FC cells are generally characterized by high
levels of RNAPII and GRO compared with all actively
transcribed genes. (C ) Genes with high levels of DNA
damage in MLL2 FC/FC cells are generally short com-
pared with all actively transcribed genes. The whiskers
denote minimum to maximum. P-values were deter-
mined by t-test.
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Histone modification is known to be highly dynamic
around the elongating polymerase (Venkatesh and Work-
man 2015). One way of explaining the surprising finding
that steady-state levels of histone methylation are not de-
creased byMLL2mutation would thus be if MLL2 only af-
fects the dynamics of histone H3K4 methylation as an
individual RNAPII molecule moves across a gene (i.e.,
cotranscriptional histone methylation). To investigate
this possibility, we again used the human cell lines in
which MLL2 was deleted or lacked the catalytic SET
domain (Guo et al. 2012, 2013), immunoprecipitated hu-
man RNAPII, and performed histone H3K4Western blots
on the resulting material. Similar amounts of histone H3
were associated with RNAPII in wild-type and mutant
cell lines (Fig. 5F, bottom panel). However, while histone
H3wasmono-, di-, and trimethylated at Lys4 in wild-type
cells, especiallymono- and trimethylation on these nucle-
osomes were highly depleted in MLL2 mutated cells
(Fig. 5F), suggesting that transcription-associated histone
methylation is indeed perturbed in these cells. To further
expand on this finding, we performed ChIP/reChIP ex-
periments, using anti-RNAPII antibodies for the first
round of immunoprecipitation and then anti-histone H3
methylation antibodies for the second round of immuno-
precipitation from the RNAPII-associated material. Al-
though technically challenging, in this approach, we
also observed a significant depletion of RNAPII-associat-
ed histone H3 methylation using the highly expressed
and highly affected MALAT1 gene as proxy for the most
MLL2-affected genes (Fig. 5G).
Together, these results indicate that MLL2 plays an im-
portant role in cotranscriptional histone methylation, af-
fecting only the histones in the immediate surroundings
of elongating RNAPII.
Increased mutation burden in the absence
of MLL2
We now returned to the finding that histone genes in par-
ticular were affected byMLL2mutation. Interestingly, in
this connection, recent data indicate that up to 80% of pa-
tients with follicular lymphoma carryMLL2mutation (Li
et al. 2014; Okosun et al. 2014), a notable example of a
strong cancer driver mutation. Significantly, the same pa-
tient cohort also presented a high level of mutations in
histone genes. Intriguingly, as described above, histone
genes presented elevated levels of DNA damage
(γH2AX) in the mouse MLL2 FC/FC cells. This raised
the possibility that MLL2 mutation results in histone
gene mutation in both mouse cell lines and human can-
cer; i.e., the histone mutations detected in follicular lym-
phoma might be caused by MLL2mutation.
Figure 5. MLL2 associates with RNAPII.
(A, left) Profiles of H3K4me1, normalized
to H3, of all active genes in MEFs. (Right)
The same, but for the genes with the most
DNA damage in MLL2 FC/FC cells. (B)
MLL2 and RNAPII are present at HIST1
genes. (C ) ChIP-seq meta-analysis of RNA-
PII and MLL2 gene profiles in HCT116
cells. (B,C ) Original data from ENCODE
(The ENCODE Project Consortium, 2012)
and Hu et al. (2013). (D) MLL2-Flag coim-
munoprecipitation (co-IP) experiments
with HCT116 nuclear extracts. (E) As in
D, but RNAPII immunoprecipitation
(RNAPII-IP). The input represents 10% of
the extract used for the immunoprecipita-
tions, except for the RNAPII immunopre-
cipitations, where it was 1%. Parental
cells (P) without MLL2-Flag were used as
control. (F ) RNAPII coimmunoprecipitated
from HCT116 high-salt-extracted nuclear
extracts and Western with antibodies
against methylated H3K4 or H3 as indicat-
ed. (G) ChIP/reChIP experiments using
HCT116 cells at theMALAT1 locus. Prima-
ry ChIP was performed using anti-RNAPII
antibodies; reChIP was with antibodies
against methylated H3K4 or H3 as indicat-
ed. Error bars represent SEM. n = 2. P-values
were determined by t-test. (WT) Parental
cell line; (19) KO19; (34) KO34; (Δ) ΔSET.
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To try to experimentally address this intriguing possi-
bility, we first used the two human MLL2 knockout cell
lines and the ΔSET cell line, with the parental HCT116
cell line as control, to perform exome capture sequencing
experiments to identify mutations that occurred upon
MLL2 deletion (Fig. 6A, top). Because of the sequencing
depth required, these experiments were restricted to the
histone genes that could be targeted with high coverage
and a few other genes that were strongly affected in
MLL2 FC/FC cells. We also tested a short, highly tran-
scribed control gene (RPLP0), which was largely unaffect-
ed by MLL2 mutation. Remarkably, several mutations in
target genes were independently established in the target
genes in two out of three and sometimes even all three
MLL2 mutated human cell lines (Fig. 6A, bottom), while
no mutations were detected in the RPLP0 control gene.
It might be argued that these cell lines have simply ran-
domly accumulated mutations. However, the fact that
the same mutations were detected in the MLL2 mutated
cells (which were independently derived) (Guo et al.
2012, 2013) but not in the parental control cells strongly
suggests that MLL2 deletion led to the mutations. It is
relevant to note that, as one might have expected, the
majority of the established mutations gave rise to silent
or intronic mutations or mutations upstream of/down-
stream from the ORF that would not be expected to affect
the protein product. A limited number of mutations did
result in truncated or improperly terminated proteins,
though these were not among the recurrent mutations
(Fig. 6A, bottom).
Finally, we also performed a similar experiment in
mouse cells in which MLL2 could be inducibly mutated.
Here, we compared the mutations arising in cells that
had the same genetic background prior to the experiment;
i.e., that of the F/F cells. Cells were grown for 30 d with or
without excision ofMLL2onday 1 before analyzing the ge-
netic profile by deep sequencing of the selected genes, as
described above. Again, we considered the gene sequences
found at the start of the experiment as baseline and then
askedwhether anymutations could be detected 30 d later,
after ∼45 cell doublings (Fig. 6B). In agreement with an es-
timated mutation rate of ∼6 × 10−8 mutations per nucleo-
tide site per generation for mouse cells in culture (Li et al.
1983), only one mutation was detected at the end of this
Sequence-capture 38 genomic DNA targets and non-targets
Parental HCT116  -   MLL2 KO19   -   MLL2 KO 34    -   MLL2 ∆SET A
B
Deep Sequence DNA (>500x coverage; Ion-Torrent); Identify mutations
-CRE       24 hrs        +CRE
Parental F/F cells 
30 days
F/F             FC/FC
Sequence-capture 27 genomic DNA targets and non-targets
Deep Sequence DNA (>500x coverage; Ion-Torrent); Identify mutations
No FC/FC Variant Gene AA
1 chr3:96239935 C>T HIST2H2AA2 G>S
2 chr17:29093980 A>-C CDKN1A Intron
3 chr3:96245896 G>A HIST2H3C1 5' UTR
4 chr1:134077218 G>+T BTG2 3' UTR
5 chr3:96220375 C>+A Down HIST2H2AB/AC Downstream
6 chr1:134078729 T>+G BTG2 Intron
7 chr17:29091657 T>-ATG CDKN1A Intron
No F/F Variant Gene AA
1 chr10:117711046 A>-T Up MDM2 Upstream
MLL2 FC/FC
MLL2 F/F
No Position Variant KO19 KO34 DSET Gene AA
1 chr5:137802023 G>-T YES YES YES EGR1 Intron
2 chr5:137802103 C>T YES YES - EGR1 Intron
3 chr5:137804455 C>-A YES YES YES EGR1 5'UTR
4 chr6:134495262 A>-G YES YES - SGK1 Intron
5 chr6:26199927 G>A YES YES YES HIST1H2BF K>K
6 chr6:26234399 T>-C - YES YES HIST1H1D Upstream
7 chr6:26251938 C>A YES YES - HIST1H2BH T>T
8 chr6:27806908 G>A YES YES - HIST1H2BN Downstream
9 chr6:36647758 A>-G - YES YES CDKN1A Intron
10 chr6:36648284 C>+G - YES YES CDKN1A Intron
11 chr1:203274507 G>-A - YES - BTG2 Upstream
12 chr1:203275928 G>-CA - - YES BTG2 Intron
13 chr5:137801396 G>+C YES - - EGR1 5'UTR
14 chr6:134496782 G>+C - YES - SGK1 Out of frame and stop codon 
15 chr6:134499191 G>-A - YES YES SGK1 Intron
16 chr6:26235109 G>+T YES - - HIST1H1D Out of frame and stop codon
17 chr6:27805903 C>-G - YES - HIST1H2AK Out of frame and stop codon 
18 chr6:27834633 C>-T - YES - HIST1H1B Cancels the stop codon 
19 chr6:36647185 A>-C YES - - CDKN1A Intron
20 chr12:69201933 C>+G - - YES MDM2 Upstream
21 chr12:69201945 T>+G - - YES MDM2 Upstream
Figure 6. MLL2 disruption results in increased muta-
tion rates in cell lines. (A, top) Experimental approach.
(Bottom) Mutations detected by Ion Torrent deep se-
quencing in MLL2 mutated HCT116 cells. (>) A substi-
tution; (−) a deletion; (+) an insertion. The AA column
indicates the relative position of the affected amino
acid. (B, top) Experimental approach. (Bottom) Muta-
tions detected in the FC/FC or parental F/F cells 30 d af-
ter MLL2 excision.
Kantidakis et al.
416 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on October 15, 2018 - Published by genesdev.cshlp.orgDownloaded from 
growth period in the F/F control cells (P = 0.13, binomial
test). In the MLL2 FC/FC cells, however, we found seven
mutations (P = 1.4 × 10−10), again indicating that MLL2
mutation indeed results in a hypermutation phenotype.
Together, these data above strongly support the idea
that loss ofMLL2 function can inducemutations in genes,
providing a likely explanation for previous observations in
follicular lymphoma patients.
Discussion
Recent genome-wide cancer studies have shown that
MLL2 is a tumor suppressor that is mutated in a large
number of different cancers. Indeed, in a recent survey of
frequent cancermutations, only a fewwell-studied drivers
such as p53, B-raf, K-ras, and PTEN are more frequently
mutated (https://www.intogen.org/search; Gonzalez-Pe-
rez et al. 2013). Here we show that MLL2 plays an impor-
tant role in maintaining genomic stability, providing a
new conceptual basis for understanding its widespread
role in tumorigenesis. Using a variety of cell biological
and genome-wide assays, we show thatMLL2 inactivation
results in genomic alterations (ranging from point muta-
tions to gains and losses of genomic regions) and overall
instability at the chromosomal level. Our data suggest
that this can be explained at least partly by elevated RNA-
PII transcription stress in especially highly expressed,
short genes, correlating with increased DNA damage in
these genes.
A role for MLL2 in ensuring genome stability
The data presented here strongly indicate thatMLL2 is re-
quired to maintain genome stability. The evidence was
obtained at a number of levels and in both mouse and hu-
man cells. For example, cells mutated forMLL2 display a
number of traits characteristic of genome instability, such
as elevated levels of sister chromatid exchange, GCAs,
53BP1 foci, and micronuclei. In apparent agreement
with our data, DNA damage and increased levels of reac-
tive oxygen species have also recently been reported in
bone marrow hematopoietic stem cells expressing the
MLL-AF9 oncogene and lacking MLL2 (Santos et al.
2014). Moreover, CGH showed that a number of recurring
chromosomal losses and gains are detected in MLL2 mu-
tated cells. Finally, as described in more detail below,
MLL2mutation results in point mutations in genes.
Interestingly, similar but not identical observations
on genome instability were made in mouse and human
cells. The variations in instability observed between
mouse fibroblasts and human colon carcinoma cells
are unsurprising and, aside from the intrinsic dissimilari-
ties between such cells,might conceivably bedue to differ-
ences between stable human cell lines that have already
adapted to life without MLL2 and the mouse cells, which
are challenged by the sudden absence of it. Alternatively
or additionally, the differencesmight be due to differential
expression of other HMTs. Indeed, while only MLL2 was
targeted inourmouse cellmodel, thehumanMLL2knock-
out cells are known to also lack MLL3 expression (Guo
et al. 2012). Under certain circumstances, MLL3 can sub-
stitute for MLL2 (Lee et al. 2009), and a role for other
HMTs in compensation for MLL2 cannot be excluded.
In order to investigate exactly where in the genome
DNA damage occurs, we performed γH2AX ChIP-seq ex-
periments in normal andMLL2mutated cells. Interesting-
ly, γH2AX can spread for megabases in response to a site-
specific and persistent DNA double-strand break (Meier
et al. 2007). In contrast, the spontaneous transcription-
associated DNA damage described here does not give
rise to such spreading. This might be because it does not
give rise to persistent double-stranded breaks or because
a lesion, even if it is a DNA double-strand break, will
only arise at any single specific position in a tiny fraction
of cells in a normal cell population. Indeed, our data show
that genes with an elevated likelihood of instability
display only modest γH2AX increases over the region. Im-
portantly, in cellsmutated forMLL2, we observed a signif-
icant increase in γH2AX and transcription stress in a
subset of genes relative to normal cells. These genes
were typically short and highly expressed. Indeed, it is
possible that their preferential display of elevated levels
of DNA damage (γH2AX) and point mutations is coupled
to their transcription level; i.e., that MLL2 mutation af-
fects transcription stress at most genes, but its effects
are more likely to be detected in highly active ones. In ap-
parent agreement with this idea, the genes most affected
byMLL2mutation overlap significantly with cancer-asso-
ciated ERFSs, which are themselves enriched for short,
highly active genes (Barlow et al. 2013).
Together, the available data thus strongly support the
idea that, in the absence of MLL2, the process of tran-
scription generally induces DNA damage and genome
instability.
A role for MLL2 in histone methylation during transcript
elongation
Recent studies in human, mouse, and Drosophila cells
show that MLL2 or itsDrosophila homolog, Trithorax-re-
lated (TRR), is present at the TSS of actively transcribed
genes (Herz et al. 2012; Hu et al. 2013; Lee et al. 2013).
Strikingly, our metagene analysis of previous data (The
ENCODE Project Consortium 2012; Hu et al. 2013)
shows that RNAPII and MLL2 actually have very similar
occupancy profiles across genes. In agreement with this,
we found that MLL2 mutation affects transcript elonga-
tion, in particular at highly active genes: In the absence
of MLL2, RNAPII density increases in the transcribed re-
gion without concomitant increases in nascent RNA syn-
thesis, indicating slow elongation and/or transcription
stress. Moreover, MLL2 interacts with RNAPII and
RECQL5, which plays an important role in transcription-
al elongation genome-wide (Saponaro et al. 2014). MLL2
is thus part of the protein machinery that ensures smooth
transcription and transcript elongation in particular.
Although it is well established that MLL2 is a histone
methyltransferase, we were unable to detect marked
changes in H3K4 methylation either globally or at the
MLL2 in transcription and genome instability
GENES & DEVELOPMENT 417
 Cold Spring Harbor Laboratory Press on October 15, 2018 - Published by genesdev.cshlp.orgDownloaded from 
genes with most DNA damage in MLL2 mutated cells.
This is in line with previous work showing that decreases
in histone H3K4methylation, primarily mono- and dime-
thylation, can be detected only at enhancers inMLL2mu-
tated human cells (Hu et al. 2013; Lee et al. 2013; Cheng
et al. 2014). Remarkably, however, MLL2 mutation
greatly affects H3K4 methylation of RNAPII-associated
nucleosomes, as shown both by RNAPII coprecipita-
tion and ChIP analysis. Together with the realization
that the MLL2 profile across genes resembles that of
RNAPII, this indicates a role for MLL2 in cotranscrip-
tional histone H3K4methylation. Actually, it is tempting
to speculate that the H3K4 methylation marks typifying
enhancers are established by MLL2 and recruited there
byRNAPII transcribing enhancer RNAand that the differ-
ences in steady-state histone marks between enhancers
and gene regions are due to, for example, promoter-depen-
dent loading of proteins that ensure dynamic histone
modification.
In any case, it is an obvious possibility that lack of
cotranscriptional histone methylation resulting from
MLL2 mutation causes problems for transcript elonga-
tion, especially at highly active genes; that this in turn re-
sults in transcription stress (RNAPII backtracking in
particular); and that the ensuing clashes with replication
forks then lead to genome instability, including muta-
tions in genes. Alternatively, or additionally, the change
in histone methylation dynamics in genes might in itself
cause problems for the replication machinery, again giv-
ing rise to mutation and genome instability.
It is also worth noting that some aspects of genome in-
stability observed upon MLL2 mutation were transient.
To the best of our knowledge, such instability followed
by relative stabilization has not previously been observed.
In this connection, we note that the small but consistent
relative increase in histone methylation at the genes
with the most DNA damage in our mouse cells and in hu-
man cells (Hu et al. 2013) suggests that other HMTs can
(over)compensate for its absence. The mechanisms that
compensate for theabsenceofMLL2might take time to es-
tablish,whichmight in turn explainwhycertain aspects of
genome instability, such as 53BP1 foci and micronuclei,
were seen only in the immediate wake of loosing MLL2
but not after longer cell growth. The need for such com-
pensation—in all likelihood by other HMTs associating
with RNAPII—might also help explain why mere muta-
tion of the SETdomain ofMLL2 appears to be significantly
more genome-destabilizing than a complete loss ofMLL2.
MLL2 mutation and the implications for cancer
It was previously suggested that MLL2 might impact can-
cer through its effect on enhancers (Herz et al. 2014).
Without contradicting previous studies, we propose an
additional way in which MLL2 may broadly impact carci-
nogenesis. We thus favor a model in which MLL2 in-
activation, although likely not in itself essential for
tumorigenesis (Issaeva et al. 2007), drives tumor evolution
through the gains and losses of genomic regions and/or in-
creased gene mutation; in other words, through a wave of
genomic instability, particularly in active genes, fueling
cancer evolution and heterogeneity. We believe that this
model can nicely explain why MLL2 is mutated in so
many different types of cancers.
MLL2 is particularlyhighlymutated in follicular anddif-
fuse large B-cell lymphoma (Pasqualucci et al. 2011; Lohr
et al. 2012; Morin et al. 2013; Okosun et al. 2014). In these
studies, mutations in histone genes were identified along-
side those in MLL2. Remarkably, several histone genes
were in the group of genes that showed the most DNA
damage in ourMLL2mutated cells: These had high levels
of γH2AX and were typically characterized by slow RNA-
PII transcript elongation/transcription stress. This sup-
ports the idea that deletion of MLL2 results in mutation
in genes, including histone genes. We directly examined
this possibility bydeep sequencing several genes innormal
and MLL2 mutated cells. Gratifyingly, compared with
controls, we detected several gene mutations in both hu-
man andmouse cell lines withMLL2mutation. Although
these results were performed in cell lines, they are in
strong support of the idea thatMLL2mutation also caused
the histone mutations observed in follicular and diffuse
large B-cell lymphoma.
It is important to stress that the mutations that we de-
tected are in all likelihood only the tip of the iceberg; i.e.,
they merely represent a few specific sites in highly ex-
pressed genes,which, in these particular cell lines, become
mutated repeatedly enough to become detectable. In other
cell types and contexts, othermutation sites in other genes
might well be prevalent. Interestingly, whole-tumor ge-
nome sequencing data indicate that hot spots of mutation
are enriched in the transcribed region within the first 2 kb
after theTSS, starting to rise immediately upon the transit
from transcriptional initiation to active elongation (Kho-
dabakhshi et al. 2012).We suggest thatMLL2 is particular-
ly important to suppress such mutation, at least partly by
reducing replication problems resulting from clashes with
RNAPII undergoing transcription stress, and that, in its ab-
sence, cells therefore gain a “mutator” phenotype (Loeb
2001), which is particularly damaging because it preferen-
tially targets active genes.
Materials and methods
Protein work
Immunoprecipitation and mass spectroscopy were performed as
previously described (Aygun et al. 2008). Nuclear extracts were
prepared using the Episeeker nuclear extraction kit (Abcam,
ab113474) and treated with benzonase prior to immunoprecipita-
tion and Western blotting. Antibodies to RECQL5 (Abcam,
ab91422), Flag (Cell Signaling, 2368S), PTIP (Abcam, ab70434),
and RNAPII (4H8 or 8WG16, Abcam) were used. The RNAPII-
Ser2P and RNAPII-Ser7P antibodies were kind gifts from the
Eick laboratory.
Genome instability assays
Metaphase spreads, sister chromatid exchange assays, immuno-
fluorescence staining, and counting of micronuclei were per-
formed using standard assays and are described in the
Kantidakis et al.
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Supplemental Material. Mouse CGH experiments were per-
formed using NimbleGen microarrays as previously described
(Saponaro et al. 2014). HumanCGH experiments were performed
using Agilent microarrays according to the manufacturer’s
recommendations.
Genome-wide analysis
ChIP,ChIP-seq, andGRO-seq experimentswereperformedas pre-
viously described (Saponaro et al. 2014). Ion Torrent sequencing
and analysis were based on primers designed by the Ion Ampliseq
designer (Life Technologies). The supporting data sets have been
deposited in the Gene Expression Omnibus database (http://ncbi
.nlm.nih.gov/geo) with accession number GSE73130.
For further details, please see the Supplemental Material.
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